| Literature DB >> 12176986 |
Linlin Ma1, William A Rudert, Jo Harnaha, Marietta Wright, Jennifer Machen, Robert Lakomy, Shiguang Qian, Lina Lu, Paul D Robbins, Massimo Trucco, Nick Giannoukakis.
Abstract
Glucosamine is a naturally occurring derivative of glucose and is an essential component of glycoproteins and proteoglycans, important constituents of many eukaryotic proteins. In cells, glucosamine is produced enzymatically by the amidation of glucose 6-phosphate and can then be further modified by acetylation to result in N-acetylglucosamine. Commercially, glucosamine is sold over-the-counter to relieve arthritis. Although there is evidence in favor of the beneficial effects of glucosamine, the mechanism is unknown. Our data demonstrate that glucosamine suppresses the activation of T-lymphoblasts and dendritic cells in vitro as well as allogeneic mixed leukocyte reactivity in a dose-dependent manner. There was no inherent cellular toxicity involved in the inhibition, and the activity was not reproducible with other amine sugars. More importantly, glucosamine administration prolonged allogeneic cardiac allograft survival in vivo. We conclude that, despite its documented effects on insulin sensitivity, glucosamine possesses immunosuppressive activity and could be beneficial as an immunosuppressive agent.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12176986 DOI: 10.1074/jbc.M204924200
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157